On Friday, Advanced Semiconductor Engineering (ADR)(NYSE:ASX)’s shares inclined 2.19% to $5.60.
Advanced Semiconductor Engineering, Inc. (ASX) the world’s largest independent provider of packaging and testing services, recently stated unaudited net revenues[1] of NT$70,222 million for the second quarter of 2015 (2Q15), up by 20% year-over-year and up by 9% sequentially. Net income attributable to shareholders of the parent for the quarter totaled NT$3,652 million, down from a net income attributable to shareholders of the parent of NT$5,106 million in 2Q14 and down from a net income attributable to shareholders of the parent of NT$4,469 million in 1Q15. Basic earnings per share for the quarter were NT$0.48 (or US$0.077 per ADS), contrast to basic earnings per share of NT$0.66 for 2Q14 and NT$0.58 for 1Q15. Diluted earnings per share for the quarter were NT$0.43 (or US$0.070 per ADS), contrast to diluted earnings per share of NT$0.65 for 2Q14 and NT$0.56 for 1Q15.
Advanced Semiconductor Engineering, Inc. provides semiconductor packaging and testing services in the United States, Taiwan, Asia, Europe, and internationally. It operates through Packaging, Testing, and Electronic Manufacturing Services (EMS) segments.
Siliconware Precision Industries (ADR) (NASDAQ:SPIL)’s shares dropped -0.70% to $5.66.
Siliconware Precision Industries Co., Ltd. (SPIL) declared that its merged sales revenues for the second quarter of 2015 were NT$ 21,240 million, which represented a 2.1% growth in revenues contrast to the first quarter of 2015 and a 3.1% decline in revenues contrast to the second quarter of 2014. SPIL stated a net income of NT$ 3,677 million for the second quarter of 2015, contrast with a net income of NT$ 2,615 million and a net income of NT$ 3,375 million for the first quarter of 2015 and the second quarter of 2014, respectively.
Basic earnings per share for this quarter was NT$ 1.18, and diluted earnings per ordinary share was NT$ 0.93. Basic earnings per ADS for this quarter was US$ 0.19, and diluted earnings per ADS was US$ 0.15.
Operating results review:
- For the second quarter of 2015, net revenues from IC packaging were NT$ 18,726 million and represented 88% of total net revenues. Net revenues from testing operations were NT$ 2,514 million and represented 12% of total net revenues.
- Cost of goods sold was NT$ 15,459 million, representing an enhance of 0.7% contrast to the first quarter of 2015 and a decrease of 4.9% contrast to the second quarter of 2014.
- Raw materials costs were NT$ 6,704 million for the second quarter of 2015 and represented 31.6% of total net revenues, whereas raw materials costs were NT$ 6,768 million and represented 32.5% of total net revenues for the first quarter of 2015.
- The accrued expenses of bonuses to employees accounted for under cost of goods sold totaled NT$ 258 million.
Siliconware Precision Industries Co., Ltd. provides semiconductor packaging and testing services to semiconductor suppliers worldwide. Its packaging and testing solutions comprise advanced packages, substrate packages, and lead-frame packages, in addition to testing for logic and mixed signal devices to measure and ensure the performance, functionality, and reliability of packaged semiconductor devices.
At the end of Friday’s trade, Zeltiq Aesthetics Inc (NASDAQ:ZLTQ)‘s shares surged 6.98% to $34.35
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, recently declared financial results for the second quarter 2015.
Second Quarter 2015 Financial Review
Total revenue for the second quarter 2015 was $64.4 million, compriseing of $32.0 million of system revenue and $32.4 million of consumable revenue. This compares to total revenue of $47.1 million, compriseing of $25.4 million of system revenue and $21.7 million of consumable revenue for the second quarter 2014. Total revenue cycles shipped raised 52% to 252,642 for the second quarter 2015, contrast to 166,116 for the second quarter 2014.
Gross profit was $46.3 million, or 72% of revenue, for the second quarter 2015, contrast to gross profit of $33.4 million, or 71% of revenue, for the second quarter 2014. Operating expenses for the second quarter 2015 were $44.7 million, contrast to $30.6 million for the second quarter 2014.
Operating income for the second quarter 2015 was $1.7 million, contrast to operating income of $2.8 million for the second quarter 2014. Net income for the second quarter 2015 was $1.2 million, or $0.03 per share, contrast to net income of $2.8 million for the second quarter 2014, or $0.07 per share.
ZELTIQ Aesthetics, Inc., a medical technology company, engages in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled cooling technology to selectively reduce stubborn fat bulges. ZELTIQ Aesthetics, Inc. sells its products through a direct sales force, in addition to through a network of distributors to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007.
Danaher Corporation(NYSE:DHR), ended its Friday’s trading session with -0.33% loss, and closed at $91.56.
Danaher Corporation (DHR) declared record results for the second quarter 2015.
For the quarter ended July 3, 2015, non-GAAP adjusted diluted net earnings per share were $1.08, which reflects the adjustments identified in the attached reconciliation plan. On a GAAP basis, diluted net earnings for the second quarter were $696 million, or $0.97 per share. Revenue for the second quarter 2015 raised 3.5% to $5.1 billion with core revenues also increasing 3.5%.
The Company anticipates that non-GAAP, adjusted diluted net earnings per share from ongoing operations for the third quarter 2015 will be in the range of $1.00 to $1.04. The Company is raising its full year 2015 non-GAAP adjusted diluted net earnings per share from ongoing operations guidance to $4.25 to $4.33 from $4.23 to $4.33.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; hardware and software solutions to deploy, manage, and secure communication network technologies and services; and tools, toolboxes, and automotive maintenance equipment. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel administration, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet administration.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
